Ovarian angiotensin-converting enzyme activity in humans: relationship to estradiol, age, and uterine pathology
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The present study was designed to measure angiotensin-converting enzyme (ACE) activity in the human ovary and in serum and to relate this activity to age, serum estradiol levels, and uterine and endometrial pathology. ACE activity was determined in 56 females by a radiometric assay using [3H]hippuryl-glycyl-glycine as substrate. Ovarian ACE activity, but not serum ACE, was found to increase with age (P < 0.01) and was significantly greater in postmenopausal subjects (n = 31; 1.35 +/- 0.05 nmol/mg.min) than in subjects with active ovaries (n = 21; 0.65 +/- 0.2 nmol/mg.min; P = 0.0033). Ovarian ACE activities in fertile women in the preovulatory phase (n = 14) and the postovulatory phase (n = 7) were not statistically different (0.66 +/- 0.23 and 0.63 +/- 0.17 nmol/mg.min, respectively). Serum ACE activities were similar in females with active and nonactive ovaries (87.6 +/- 5.0 vs. 81.7 +/- 5.3 nmol/mL-min, respectively). Serum estradiol levels in fertile women were significantly higher than those in postmenopausal women (P = 0.0023). Serum estradiol levels were negatively correlated with age (r = -0.46; P = 0.0041) and were not correlated with either serum ACE activity (r = 0.080; P = NS) or ovarian ACE activity. In summary, human ovarian ACE activity, but not serum ACE, is positively correlated with age. Serum estradiol levels decrease with age, but are not correlated with either ovarian or serum ACE activity. Endogenous serum estradiol levels had no apparent effect on ovarian or serum ACE activity. The presence of uterine pathology affects ovarian ACE activity. The cause of the increased ovarian ACE activity is not clear, but may be related to the aging process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sealey, J. E., Itskovitz-Eldor, J., Rubattu, S., James, G. D., August, P., Thaler, I., Levron, J., & Laragh, J. H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027239 · Cited by 115
Oral contraceptives and hypertension.
Woods, J. W. (1988) · Hypertension · doi:10.1161/01.hyp.11.3_pt_2.ii11 · Cited by 111
Immunohistochemical localization of renin and angiotensin II in human ovaries
Palumbo, A., Jones, C., Lightman, A., Carcangiu, M. L., DeCherney, A. H., & Naftolin, F. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90077-x · Cited by 75
Cited by
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Local Renin-Angiotensin System in the Reproductive System
Herr, D., Bekes, I., & Wulff, C. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00150 · Cited by 91
Involvement of ACE2/Ang-(1-7)/MAS1 Axis in the Regulation of Ovarian Function in Mammals
Domińska, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134572 · Cited by 38
“In patients with active ovaries, ovarian ACE activity was similar in the pre- and postovulatory phases [55].”
BackgroundPhysiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system
Liu, Y., Hao, H., Lan, T., Jia, R., Cao, M., Zhou, L., Zhao, Z., & Pan, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1080285 · Cited by 20
Metadata
- Authors
- Erman, A.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1996-03-01
- Volume
- 81
- Issue
- 3
- Pages
- 1104-1107
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2041633835
- Cited by
- 21
- References
- 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.